Colgate-Palmolive (NYSE:CL) Shares Sold by Well Done LLC

Well Done LLC reduced its position in shares of Colgate-Palmolive (NYSE:CL) by 0.5% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 28,518 shares of the company’s stock after selling 153 shares during the period. Well Done LLC’s holdings in Colgate-Palmolive were worth $2,960,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in the company. Fisher Asset Management LLC grew its stake in shares of Colgate-Palmolive by 1,010.7% in the fourth quarter. Fisher Asset Management LLC now owns 3,210 shares of the company’s stock worth $256,000 after purchasing an additional 2,921 shares in the last quarter. Nomura Holdings Inc. grew its stake in shares of Colgate-Palmolive by 520.7% in the fourth quarter. Nomura Holdings Inc. now owns 16,592 shares of the company’s stock worth $1,323,000 after purchasing an additional 20,536 shares in the last quarter. CWM LLC grew its stake in shares of Colgate-Palmolive by 4.0% in the first quarter. CWM LLC now owns 23,178 shares of the company’s stock worth $2,087,000 after purchasing an additional 889 shares in the last quarter. Los Angeles Capital Management LLC grew its stake in shares of Colgate-Palmolive by 27.7% in the first quarter. Los Angeles Capital Management LLC now owns 103,128 shares of the company’s stock worth $9,287,000 after purchasing an additional 22,381 shares in the last quarter. Finally, Massmutual Trust Co. FSB ADV grew its stake in shares of Colgate-Palmolive by 70.0% in the first quarter. Massmutual Trust Co. FSB ADV now owns 3,978 shares of the company’s stock worth $358,000 after purchasing an additional 1,638 shares in the last quarter. 80.41% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

CL has been the subject of several recent analyst reports. Hsbc Global Res cut Colgate-Palmolive from a “strong-buy” rating to a “hold” rating in a research note on Friday, July 26th. Sanford C. Bernstein raised their target price on Colgate-Palmolive from $100.00 to $103.00 and gave the company a “market perform” rating in a research note on Tuesday, July 30th. Wells Fargo & Company downgraded Colgate-Palmolive from an “equal weight” rating to an “underweight” rating and set a $100.00 target price for the company. in a report on Monday, September 16th. Evercore ISI upped their target price on Colgate-Palmolive from $100.00 to $106.00 and gave the company an “outperform” rating in a report on Thursday, July 18th. Finally, Deutsche Bank Aktiengesellschaft downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating and upped their target price for the company from $107.00 to $109.00 in a report on Monday, September 9th. One analyst has rated the stock with a sell rating, eight have given a hold rating and fourteen have given a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $106.00.

Colgate-Palmolive Stock Down 1.2 %

Shares of NYSE CL traded down $1.24 during mid-day trading on Friday, reaching $99.29. 466,426 shares of the company traded hands, compared to its average volume of 4,320,576. The company has a debt-to-equity ratio of 16.90, a quick ratio of 0.70 and a current ratio of 1.06. The stock has a market cap of $81.46 billion, a PE ratio of 31.81, a price-to-earnings-growth ratio of 3.54 and a beta of 0.40. The company’s fifty day moving average is $103.46 and its two-hundred day moving average is $97.46. Colgate-Palmolive has a fifty-two week low of $71.46 and a fifty-two week high of $109.30.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, July 26th. The company reported $0.91 EPS for the quarter, beating analysts’ consensus estimates of $0.87 by $0.04. The business had revenue of $5.06 billion for the quarter, compared to analyst estimates of $5 billion. Colgate-Palmolive had a return on equity of 470.19% and a net margin of 14.21%. The firm’s revenue for the quarter was up 4.9% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.77 EPS. On average, analysts expect that Colgate-Palmolive will post 3.57 earnings per share for the current year.

Colgate-Palmolive Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.01%. The ex-dividend date of this dividend is Friday, October 18th. Colgate-Palmolive’s dividend payout ratio is 63.29%.

Insider Activity

In other Colgate-Palmolive news, Director Martina Hundmejean sold 2,313 shares of the firm’s stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total value of $240,228.18. Following the sale, the director now owns 11,755 shares of the company’s stock, valued at $1,220,874.30. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. In other Colgate-Palmolive news, Director Martina Hundmejean sold 2,313 shares of the firm’s stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total value of $240,228.18. Following the sale, the director now owns 11,755 shares of the company’s stock, valued at $1,220,874.30. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, insider Panagiotis Tsourapas sold 14,794 shares of the firm’s stock in a transaction that occurred on Thursday, August 8th. The shares were sold at an average price of $102.94, for a total value of $1,522,894.36. Following the completion of the sale, the insider now directly owns 5,146 shares in the company, valued at $529,729.24. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 43,490 shares of company stock valued at $4,486,063. Insiders own 0.34% of the company’s stock.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.